Press Release, 24 May 2023
Today, Realheart publishes the annual report for 2022. In addition to the regular Swedish version, a designed version is also released containing reports, collaborations and milestones during the year.
The annual report including the auditor's report and the designed English version can be found at www.realheart.se and as attachments in this press release.
For more information please contact:
Ina Laura Perkins, CEO
Phone: +46(0)70 406 49 21
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart® TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation. A unique concept in the medical technology world.Realheart Releases the Annual Report for 2022 (PDF)